Cargando…

Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma

Clinical and genetic risk factors are currently used in multiple myeloma (MM) to stratify patients and to design specific therapies. However, these systems do not capture the heterogeneity of the disease supporting the development of new prognostic factors. In this study, we identified active promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valcárcel, Luis V., Amundarain, Ane, Kulis, Marta, Charalampopoulou, Stella, Melnick, Ari, San Miguel, Jesús, Martín-Subero, José I., Planes, Francisco J., Agirre, Xabier, Prosper, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478642/ https://www.ncbi.nlm.nih.gov/pubmed/33972667 http://dx.doi.org/10.1038/s41375-021-01263-9

Ejemplares similares

Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma
por: Amundarain, Ane, et al.
Publicado: (2022)

The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma
por: Carrasco-León, Arantxa, et al.
Publicado: (2021)

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
por: Carrasco-Leon, Arantxa, et al.
Publicado: (2021)

BOSO: A novel feature selection algorithm for linear regression with high-dimensional data
por: Valcárcel, Luis V., et al.
Publicado: (2022)

A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism
por: Apaolaza, Iñigo, et al.
Publicado: (2022)

COBRA methods and metabolic drug targets in cancer
por: Apaolaza, Iñigo, et al.
Publicado: (2017)

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
por: Ordoñez, Raquel, et al.
Publicado: (2020)

Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response
por: Agirre, Xabier, et al.
Publicado: (2019)

An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
por: Apaolaza, Iñigo, et al.
Publicado: (2017)

Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
por: Agirre, Xabier, et al.
Publicado: (2015)

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation
por: Chatonnet, Fabrice, et al.
Publicado: (2020)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated
por: Martínez-Calle, Nicolás, et al.
Publicado: (2019)

Is immunotherapy here to stay in multiple myeloma?
por: Rodríguez-Otero, Paula, et al.
Publicado: (2017)

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
por: Rodríguez-Otero, Paula, et al.
Publicado: (2020)

Long Non-Coding RNAs in Haematological Malignancies
por: Garitano-Trojaola, Andoni, et al.
Publicado: (2013)

Correction: Ordoñez, et al.; DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters? Cancers 2019, 11, 1424
por: Ordoñez, Raquel, et al.
Publicado: (2020)

DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?
por: Ordoñez, Raquel, et al.
Publicado: (2019)

In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer
por: Pey, Jon, et al.
Publicado: (2017)

Explainable artificial intelligence for precision medicine in acute myeloid leukemia
por: Gimeno, Marian, et al.
Publicado: (2022)

Epigenetic Signatures Associated with Different Levels of Differentiation Potential in Human Stem Cells
por: Aranda, Pablo, et al.
Publicado: (2009)

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
por: Mosquera Orgueira, Adrian, et al.
Publicado: (2022)

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
por: Garcia-Gomez, Antonio, et al.
Publicado: (2021)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Prognostic factors and classification in multiple myeloma.
por: San Miguel, J. F., et al.
Publicado: (1989)

Quantification of miRNA-mRNA Interactions
por: Muniategui, Ander, et al.
Publicado: (2012)

Identifying Lethal Dependencies with HUGE Predictive Power
por: Gimeno, Marian, et al.
Publicado: (2022)

P02: PROGNOSTIC STRATIFICATION OF STANDARD RISK MULTIPLE MYELOMA DEFINED BY REVISED ISS
por: Barilà, G, et al.
Publicado: (2022)

Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
por: Maes, Ken, et al.
Publicado: (2021)

Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
por: Vilarrasa-Blasi, Roser, et al.
Publicado: (2021)

Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia
por: Vilas–Zornoza, Amaia, et al.
Publicado: (2011)

Multiple Myeloma: Risk Stratification and Toxicity Management
por: Richards, Tiffany, et al.
Publicado: (2018)

Risk Stratification and Treatment in Smoldering Multiple Myeloma
por: Lussier, Tyler, et al.
Publicado: (2021)

Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2022)

A Novel Tumor suppressor network in squamous malignancies
por: Costa, Clotilde, et al.
Publicado: (2012)

Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis
por: Visram, Alissa, et al.
Publicado: (2021)

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Genetic Markers Used for Risk Stratification in Multiple Myeloma
por: Segges, Priscilla, et al.
Publicado: (2011)

Risk Stratification in Multiple Myeloma: Putting the Pieces Together
por: Mayo, Angela, et al.
Publicado: (2016)

Multiple myeloma in Korea: risk stratification and initial treatment
por: Yoon, Sung-Soo
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hjrmlnl531c73kef3odggtg1vk